ScholarLens Back to search
2005•Critical Care MedicineRequires access

LACK OF N-ACETYLCYSTEINE (NAC) COMPLIANCE PER CLINICAL TRIALS IS ASSOCIATED WITH DEVELOPMENT OF CONTRAST-INDUCED NEPHROPATHY (CIN).

Nick Lonardo, Benjamin C. Gebhart, Gabriele K. Baraghoshi, Bill Stockdale, Matthew Whitten, Edward J. Kimball

Open publisher page 0 citations

Abstract

Lonardo, Nick W; Gebhart, Benjamin C; Baraghoshi, Gabriele K; Stockdale, Bill; Whitten, Matthew; Kimball, Edward J Author Information

About this research paper

What this paper is about

Lonardo, Nick W; Gebhart, Benjamin C; Baraghoshi, Gabriele K; Stockdale, Bill; Whitten, Matthew; Kimball, Edward J Author Information

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Lonardo, Nick W; Gebhart, Benjamin C; Baraghoshi, Gabriele K; Stockdale, Bill; Whitten, Matthew; Kimball, Edward J Author Information

Key concepts: Medicine, Acetylcysteine, Compliance (psychology), Contrast-induced nephropathy, Contrast (vision), Nephropathy, Internal medicine, Intensive care medicine

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
LACK OF N-ACETYLCYSTEINE (NAC) COMPLIANCE PER CLINICAL TRIALS IS ASSOCIATED WITH DEVELOPMENT OF CONTRAST-INDUCED NEPHROPATHY (CIN). — Research Paper | ScholarLens